Journal article
Stewart-Bluefarb syndrome: review of the literature and case report of chronic ulcer treatment with heparan sulphate (Cacipliq20®)
International wound journal, Vol.12(2), pp.169-172
04/2015
DOI: 10.1111/iwj.12074
PMCID: PMC7950802
PMID: 23556996
Abstract
Stewart-Bluefarb syndrome (SBS), also known as acroangiodermatitis or pseudo-Kaposi, is a condition rarely encountered. It involves skin lesions that are clinically similar to Kaposi sarcoma but are histologically different, and are usually secondary to an underlying arteriovenous fistula. Treatment of this disease usually involves the correction of the underlying vascular abnormality, with the mainstay of therapy ranging from compression devices for venous stasis, limited oral medications (dapsone and erythromycin) and local wound care including topical steroids. Different methods of treatment showed varied success but none is ideal. We report a case of a lower extremity ulcer in a 22-year-old male recently diagnosed with SBS successfully treated with heparan sulphate (Cacipliq20®).
Details
- Title: Subtitle
- Stewart-Bluefarb syndrome: review of the literature and case report of chronic ulcer treatment with heparan sulphate (Cacipliq20®)
- Creators
- Shady Hayek - American University of Beirut Medical CenterBishara Atiyeh - American University of Beirut Medical CenterElias Zgheib - American University of Beirut Medical Center
- Resource Type
- Journal article
- Publication Details
- International wound journal, Vol.12(2), pp.169-172
- Publisher
- Blackwell Publishing Ltd
- DOI
- 10.1111/iwj.12074
- PMID
- 23556996
- PMCID
- PMC7950802
- ISSN
- 1742-4801
- eISSN
- 1742-481X
- Number of pages
- 4
- Language
- English
- Date published
- 04/2015
- Academic Unit
- Surgery
- Record Identifier
- 9984701806402771
Metrics
3 Record Views